Aging Clocks Go Multi-Omics: The Next Generation of Biological Age Tests
Epigenetic age tests were just the prototype. A new wave of clocks stitches together DNA, proteins, metabolites, and microbes — and AI is the thread.
Vol. I · June 2026 · Evidence-informed
Fresh off the desk
All articles
→
The Latest
Protocols
Nutrition as the Missing Half of GLP-1 Therapy
A new review argues the drugs only do half the work. The other half — protein, symptom management, and a maintenance plan — happens on the plate.
Peptides
Elecoglipron: The First Credible Oral GLP-1 Pill Clears a Phase 2 Hurdle
AstraZeneca's once-daily small molecule posts placebo-controlled weight-loss data in The Lancet — and hints at a future where the obesity revolution doesn't require a needle.
Peptides
The Oral GLP-1 Era Begins: Two Pills Move Toward the Mainstream
Two new trials in The Lancet put the first credible oral, non-peptide GLP-1 drugs on the runway — a shift that could change who actually gets access to this class.
Longevity
Staging the Aging Brain: A New Lifespan Map of Cholinergic Vulnerability
A new review proposes cognitive aging unfolds as a decades-long sequence — and that a midlife branch point may be the window where intervention matters most.
Peptides
Beyond the Scale: GLP-1s Linked to Lower Cancer Risk in Non-Diabetic Lifters with Obesity
A massive new target-trial emulation hints that semaglutide and tirzepatide may do more than shrink waistlines — they may quietly cut the odds of obesity-driven cancers. Here's what the data actually say.
Metabolic Health
Fatty Liver Isn't Sex-Neutral: What a Global Review Reveals About MASLD in Men and Women
A new narrative review pulls together population data from five continents and finds the liver behaves very differently depending on your hormones, your fat distribution, and your decade of life.
- 329
- Articles published
- 9
- Editorial beats
- 71
- Issues published
Evidence-graded◆
Every claim cited◆
Primary research sources◆
No hype, ever
Explore
Browse by section
Department
All 104 stories
→
Longevity
Longevity
Protein After 70: What a New Tracer Study Reveals About How Older Bodies Actually Absorb Amino Acids
A small but methodologically rigorous crossover trial measured how well young and older adults extract amino acids from milk, sorghum, and black beans — and the answer depends on the food.
Longevity
The Nose Knows: Why Fading Smell May Foretell Physical Decline
A long-running U.S. cohort study links weaker odor identification in older adults with later losses in balance, gait and grip — strengthening the case for smell as a low-cost biomarker of aging.
Longevity
The Mediterranean Diet's Mitochondrial Signature: A New Mechanistic Clue
Two 2026 studies move the Med-Diet story from epidemiology toward mechanism, pointing to mitochondrial microproteins and a reshaped gut microbiota as plausible reasons the pattern protects the heart and brain.
The current issue
Weekly Edition
Weekly Issue — 2026-06-21
A fully edited edition — 7 stories chosen and sequenced by the desk, with a cover, a contents page and a long-read flow. The whole magazine, in one sitting.
Department
All 80 stories
→
Metabolic Health
Metabolic Health
The Blood Test That Quietly Predicts Metabolic Trouble — Years Before It Arrives
A 23,000-adult Chinese study suggests high-sensitivity CRP, a routine inflammation marker, tracks who slides into — and out of — metabolic syndrome. For parents juggling everything, it may be a useful early signal.
Metabolic Health
HDL's U-Shape: Why 'More Good Cholesterol' May Not Mean a Sharper Brain
A new analysis of more than 7,500 older adults suggests very high HDL — long sold as the 'good' cholesterol — may track with lower cognitive scores. Here's what tired parents need to know about their own labs (and their parents' labs).
Metabolic Health
When Cutting Carbs Quiets the Immune System: Two-Year Data on Ketosis and Inflammation in Type 2 Diabetes
A new post-hoc analysis tracks inflammatory and immune markers in adults with type 2 diabetes for two years on a carb-restricted, ketogenic plan — and the signal goes well beyond blood sugar.
What readers are reading
Browse all articles
→
Most Read This Week
- Peptides Elecoglipron: The First Credible Oral GLP-1 Pill Clears a Phase 2 Hurdle
- Protocols Nutrition as the Missing Half of GLP-1 Therapy
- Peptides The Oral GLP-1 Era Begins: Two Pills Move Toward the Mainstream
- Supplements & Compounds Are U.S. Magnesium Reference Ranges 50 Years Out of Date?
- Peptides Ozempic on the OR Table: The New Pre-Surgery Fasting Playbook for GLP-1 Users
ListenBeta
Every article, narrated.
Press play and let the research come to you — each story read aloud in a natural voice, by the same writer every time. Built for the commute, the gym, or the kitchen.
Play the latest
Full audio edition · coming soon
0:00
--:--
The Pinnacle Brief
A weekly dispatch from the frontier of healthspan.
Evidence-graded summaries of the research that matters — peptides, metabolic health, regenerative medicine — distilled and always cited. No hype.
Always cited. Never sold. Unsubscribe anytime.
Free account
Make PinnacleLife yours.
Create a free account to save the research you value, like what resonates, and join the conversation — all kept to your account, on every device.
- ◆Save articles to your library
- ◆Like the research that matters
- ◆Join the conversation
- ◆Synced across your devices
Create your free account →
Already a member? Sign in
PinnacleLife
Download on theApp Store
Get it onGoogle Play
Apps coming soon